TRN Capital's private equity investments are focused on financial services and life science companies that demonstrate the potential for high growth through "industry changing" technologies or innovation.  Specific consideration is given to those companies where scientific and quantitative analysis are a major component of the value added proposition.  TRN consults and partners with co-investors in select private equity opportunites.